Skip to content
Stock screener

ESLA

Conviction 24HealthcareScan · Thu, Oct 15, 2026

Estrella Immunopharma, Inc. (ESLA) closed at $0.5390 (+69.55%) on Oct 15, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 56, RS Rating 9, -82.3% from its 52-week high, -61.2% year to date. Sector: Healthcare · Biological Products, (No Diagnostic Substances).

ESLA$0.5390+69.55%
ResistanceSupportVol 14Insider buy
63 bars

Price chart, 63 bars from Mon, Jul 20, 2026 to Thu, Oct 15, 2026. Last close $0.5390, high $0.8976, low $0.2950.

Vol MA14 10.14M
Jul 20Aug 5Aug 24Sep 10Sep 29Oct 15

Why ESLA moved

From the StockSetups movers recaps that covered ESLA, newest first. A recap states what was known that day.

Estrella Immunopharma, Inc.Biological Products, (No Diagnostic Substances)www.estrellabio.com ↗
Price0.5390
Change+69.55%
Gap-2.45%
Rel volume109.47×
Avg volume7.11M
Avg $ vol3.69M
SMA 200.4428
SMA 500.5938
SMA 2001.02
Price vs 50-9.23%
Price vs 200-47.28%
MA stackbearish
50/200 cross—
Supertrendup · 0.3045
RSI (14)56
MACD hist0.01
MACD crossbull · 0d
Stoch %K / %D44 / 21
ADX (14)50
+DI / −DI41 / 16
RSI divergence—
MACD divergence—
ATR %17.77%
ADR %16.22%
52w high3.05
52w low0.3140
From 52w high-82.33%
Above 52w low+71.66%
New 52w highNo
SqueezeOff
Bollinger width55.49%
%B0.89
Donchian pos44.20%
Donchian high0.8470
Donchian low0.2950
AVWAP (52w high)0.6963
vs AVWAP high-22.59%
AVWAP (52w low)0.5643
vs AVWAP low-4.48%
OBV trendUp
Chaikin MF (20)-0.06
Today vs 20d109.47×
Avg vol (14d)10.14M
Avg vol (20d)7.11M
Avg $ vol (20d)3.69M
Market cap23.45M
RS Rating9 / 99
RS 3m (vs SPY)-39.66%
RS 6m (vs SPY)-77.52%
RS line new highNo
Trend template1/8
Technical rank29.0
1 week+29.10%
1 month-15.77%
3 months-35.83%
6 months-67.53%
1 year-67.92%
YTD-61.22%
P/E-1.79
P/B-3.15
P/S—
P/FCF—
EPS-0.3500
Div yield—
ROE175.79%
ROA—
Debt/Eq—
Current0.20
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-78.67%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value23.35M
Revenue—
Net income-2.31M
Gross profit—
Free cash flow—
IndustryBiological Products, (No Diagnostic Substances)
ExchangeNasdaq
Shares out43.03M
Employees—
ListedMon, Oct 2, 2023
Free float10.25M
Float %27.1%
Short interest117.13K
Days to cover3.4d
Short volume61.6%
Squeeze score49 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction24 / 100
Pattern quality—
Tech rank29.0 / 100
Group rank—
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.7625
Support0.3631
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ESLA

All disclosures →
No recent disclosed trades by Congress in ESLA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ESLA · open-market 3 buys

InsiderSideShares
Liu Cheng
CEO · Incentive Stock Option · 2026-08-25
Exercise100K
Liu Cheng
CEO · Common Stock, par value $0.0001 per share · 2026-08-25
Exercise100K
Xu Jiandong
Chief Financial Officer · Incentive Share Option · 2026-08-18
Exercise100K
Xu Jiandong
Chief Financial Officer · Common Stock, par value $0.0001 per share · 2026-08-18
Exercise100K
Xu Jiandong
Chief Financial Officer · Common Stock, par value $0.0001 per share · 2025-10-07
Buy1K
Xu Jiandong
Chief Financial Officer · Common Stock, par value $0.0001 per share · 2025-09-22
Buy1K
Xu Jiandong
Chief Financial Officer · Common Stock, par value $0.0001 per share · 2025-09-11
Buy100

SEC filings

EDGAR filings in ESLA · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.